Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DermaVir Patch therapeutic immunization during suppressive HAART with analytical treatment interruption
2008-006912-39Phase 2Completed
- Sponsor
- ViroStatics
- Start
- Dec 2008
- Modality
- Vaccines & Immunotherapeutics, DNA Therapeutics → Nucleic Acid Therapeutics, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in human immunodeficiency virus infection (HIV) comparing DermaVir Patch + HAART with Placebo + HAART (2 arms). Started Dec 2008; status: completed.
02
Drugs
DermaVir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-006912-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006912-39.